MYRIAD GENETICS, INC. Other Operating Income (Expense), Net
MYRIAD GENETICS, INC. (MYGN) reported Other Operating Income (Expense), Net of -$439.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2013-11-12
- MYRIAD GENETICS, INC. other operating income (expense), net for the quarter ending 2013-09-30 was -$439.00K.
- MYRIAD GENETICS, INC. other operating income (expense), net for the quarter ending 2013-06-30 was $1.00K.
- MYRIAD GENETICS, INC. other operating income (expense), net for the quarter ending 2013-03-31 was -$111.00K, a 1950.00% decline year-over-year.
- MYRIAD GENETICS, INC. other operating income (expense), net for the quarter ending 2012-12-31 was $14.00K.
- MYRIAD GENETICS, INC. other operating income (expense), net for fiscal 2013 was -$223.00K.
- MYRIAD GENETICS, INC. other operating income (expense), net for fiscal 2012 was -$407.00K.
- MYRIAD GENETICS, INC. other operating income (expense), net for fiscal 2011 was -$353.00K, a 456.57% decline from fiscal 2010.
- MYRIAD GENETICS, INC. other operating income (expense), net for fiscal 2010 was $99.00K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2013-09-30 | -$439.00K 10-Q · filed 2013-11-12 | -$438.00K derived: sum of 2 quarters · filed 2013-11-12 | -$549.00K derived: sum of 3 quarters · filed 2013-11-12 | -$535.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | -$110.00K derived: sum of 2 quarters · filed 2013-08-14 | -$96.00K derived: sum of 3 quarters · filed 2013-08-14 | -$223.00K 10-K · filed 2013-08-14 |
| 2013-03-31 | -$111.00K 10-Q · filed 2013-05-08 | -$97.00K derived: sum of 2 quarters · filed 2013-05-08 | -$224.00K 10-Q · filed 2013-05-08 | -$433.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-12-31 | $14.00K 10-Q · filed 2013-02-06 | -$114.00K 10-Q · filed 2013-02-06 | -$322.00K derived: sum of 3 quarters · filed 2013-11-12 | -$316.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-09-30 | -$128.00K 10-Q · filed 2013-11-12 | -$336.00K derived: sum of 2 quarters · filed 2013-11-12 | -$330.00K derived: sum of 3 quarters · filed 2013-11-12 | -$394.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | -$202.00K derived: sum of 2 quarters · filed 2013-08-14 | -$266.00K derived: sum of 3 quarters · filed 2013-08-14 | -$407.00K 10-K · filed 2013-08-14 |
| 2012-03-31 | $6.00K 10-Q · filed 2013-05-08 | -$58.00K derived: sum of 2 quarters · filed 2013-05-08 | -$199.00K 10-Q · filed 2013-05-08 | -$278.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-12-31 | -$64.00K 10-Q · filed 2013-02-06 | -$205.00K 10-Q · filed 2013-02-06 | -$284.00K derived: sum of 3 quarters · filed 2013-08-14 | -$343.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-09-30 | -$140.00K 10-Q · filed 2012-11-09 | -$220.00K derived: sum of 2 quarters · filed 2013-08-14 | -$279.00K derived: sum of 3 quarters · filed 2013-08-14 | -$359.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2011-06-30 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | -$139.00K derived: sum of 2 quarters · filed 2013-08-14 | -$219.00K derived: sum of 3 quarters · filed 2013-08-14 | -$353.00K 10-K · filed 2013-08-14 |
| 2011-03-31 | -$59.00K 10-Q · filed 2012-05-02 | -$139.00K derived: sum of 2 quarters · filed 2012-05-02 | -$273.00K 10-Q · filed 2012-05-02 | |
| 2010-12-31 | -$80.00K 10-Q · filed 2012-02-01 | -$214.00K 10-Q · filed 2012-02-01 | ||
| 2010-09-30 | -$134.00K 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | $99.00K 10-K · filed 2012-08-15 | |||
| 2009-06-30 | -$2.49M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |